DMF/Vem treatment inhibited nuclear NRF2 expression and its transcriptional activity less significantly than Vem treatment did in our experiments (Figures 3A–G) but induced more melanoma cell death than Vem treatment did in vitro (Figures 1F, G) and in vivo (Figures 2G, H). This evidence concerns the gene NFE2L2 and melanoma.